CMS Open Payments · Program Year 2024
Okami Medical, Inc.
Okami Medical, Inc. reported $91,981.54 across General Payments, Research, and Ownership to 263 physicians and teaching hospitals across 263 transactions.
- $92.0K Below-median payer
- All-tracks total
- 263 Above-median volume
- Transactions
- 263 Above-median reach
- Recipients
- +$52.6K
- General Payments vs PY2023
Okami Medical, Inc. reported $91,981.54 across all CMS Open Payments tracks (General + Research + Ownership) to 263 physicians and teaching hospitals in Program Year 2024 - ranking #1206 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $91,981.54, averaging $349.74 per recipient.
How Okami Medical, Inc.'s $92.0K all-tracks total breaks down
Okami Medical, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
18/100
Total payments
F
11/100
Transaction volume
F
12/100
Physician reach
F
12/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer okami-medical-inc Okami Medical, Inc.
$92.0K · #1206/1,925 · 0.0% industry · PY2024
- TOT $92.0K
- RANK #1206
- SHARE 0.0%
- TXN 263
- RCP 263
- CAT 3
- GEN $92.0K
- ΔGEN +$52.6K
- TOP1 54.4%
- PY 2024
Volume peers
Nearest volume peer: Cardinal Health 110 LLC ($92.3K)
Okami Medical, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Okami Medical, Inc.'s CMS-reported General Payments increased by $52.6K (+133.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: OKAMI MEDICAL, INC.PY2023: OKAMI MEDICAL, INC.PY2024: Okami Medical, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $39,356.27
- PY2024
- $91,981.54
What the Data Shows for Okami Medical, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Okami Medical, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $70.5K, accounting for 76.6% of this company's General Payments and 23 transactions.
General Payment Breakdown by Type
"Consulting Fee" leads Okami Medical, Inc.'s 3-category general-payment breakdown at $70.5K, 76.6% of the reported total.
How Okami Medical, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $70.5K | 23 | 76.6% |
| Food and Beverage | $19.3K | 232 | 21.0% |
| Travel and Lodging | $2.2K | 8 | 2.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $71,601.65 (77.8%) of $91,981.54 in this company's General Payments records across 164 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Okami Medical, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Nima Kokabi
$50,059.36 across 26 reported transactions
- 2
Daniel Steven Levi
$11,925.00 across 4 reported transactions
- 3
Omar Z Chohan
$4,178.26 across 7 reported transactions
- 4
Devaraj Pyne
$3,150.00 across 2 reported transactions
- 5
Richard Grinstead
$2,289.03 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Okami Medical, Inc. ranks #1206 of 1,925 by total payments (bottom 37% by spend) but is notably more concentrated than that alone would suggest -- #548 of 1,838 by HHI (top 30% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Centerline Biomedical Inc. : $564.5K total payments, HHI 3229
- Carbofix Spine Inc : $52.0K total payments, HHI 3217
- ICU Medical Inc : $55.8K total payments, HHI 3209
- Emergent BioSolutions Inc. : $6.8K total payments, HHI 3205
- Atlas Ocular, Inc : $35.4K total payments, HHI 3194
- HF Acquisition Co. LLC : $46.1K total payments, HHI 3193
- Okami Medical, Inc. (this company) : $92.0K total payments, HHI 3180
- Levita Magnetics International Corp. : $2.4K total payments, HHI 3174
- Perspectum Diagnostics Ltd : $1.1M total payments, HHI 3165
- Veru Inc. : $149.5K total payments, HHI 3151
- Merete Technologies, Inc : $72.1K total payments, HHI 3135
- Vifor (International) Ltd. : $132.0K total payments, HHI 3112
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Okami Medical, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Okami Medical, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Okami Medical, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Mid-Atlantic Surgical Systems, LLC
Mitsubishi Tanabe Pharma Corporation
Banner Life Sciences, LLC
Supreme Orthopedic Systems, LLC
Pbg Puerto Rico LLC
Put this to use
Okami Medical, Inc. ranks #1206 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Okami Medical, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.